The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The rationale for quadrivalent influenza vaccines
Open accessAbstract
Two antigenically distinct lineages of influenza B viruses have circulated globally since 1985. However, licensed trivalent seasonal influenza vaccines contain antigens from only a single influenza B virus and thus provide limited immunity against circulating influenza B strains of the lineage not present in the vaccine. In recent years, predictions about which B lineage will predominate in an upcoming influenza season have been no better than chance alone, correct in only 5 of the 10 seasons from 2001 to 2011. Consequently, seasonal influenza vaccines could be improved by inclusion of influenza B strains of both lineages. The resulting quadrivalent influenza vaccines would allow influenza vaccination campaigns to respond more effectively to current global influenza epidemiology. Manufacturing capacity for seasonal influenza vaccines has increased sufficiently to supply quadrivalent influenza vaccines, and methods to identify the influenza B strains to include in such vaccines are in place. Multiple manufacturers have initiated clinical studies of quadrivalent influenza vaccines. Data from those studies, taken together with epidemiologic data regarding the burden of disease caused by influenza B infections, will determine the safety, effectiveness, and benefit of utilizing quadrivalent vaccines for the prevention of seasonal influenza disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Burden of influenza in healthy children and their households
Principi, N., Esposito, S., Gasparini, R., Marchisio, P., & Crovari, P. (2004) · Archives of Disease in Childhood · doi:10.1136/adc.2003.045401 · Cited by 100
RetractedMortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,965
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983
Rota, P. A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P., & Nerome, K. (1990) · Virology · doi:10.1016/0042-6822(90)90186-u · Cited by 539 · cited 2×
“This lineage was the precursor to the subsequent Yamagata lineage.(2) The Victoria lineage appears to have emerged from a minor lineage of B viruses”
BackgroundInfluenza A and B Virus Infections in Children
Peltola, V., Ziegler, T., & Ruuskanen, O. (2003) · Clinical Infectious Diseases · doi:10.1086/345909 · Cited by 274
The Evolutionary Dynamics of Human Influenza B Virus
Chen, R., & Holmes, E. C. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9119-z · Cited by 261
Reed, C., Meltzer, M. I., Finelli, L., & Fiore, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.098 · Cited by 228
Olson, D. R., Heffernan, R. T., Paladini, M., Konty, K., Weiss, D., & Mostashari, F. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040247 · Cited by 198
Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
Bodewes, R., de Mutsert, G., van der Klis, F. R. M., Ventresca, M., Wilks, S., Smith, D. J., Koopmans, M., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00396-10 · Cited by 185
Frey, S. E., Vesikari, T., Szymczakiewicz‐Multanowska, A., Lattanzi, M., Izu, A., Groth, N., & Holmes, S. J. (2010) · Clinical Infectious Diseases · doi:10.1086/656578 · Cited by 156
Belshe, R. B., Coelingh, K. L., Ambrose, C. S., Woo, J. C., & Wu, X. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.068 · Cited by 146
Self-citationLindstrom, S., Hiromoto, Y., Nishimura, H., Saito, T., Nerome, R., & Nerome, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4413-4426.1999 · Cited by 138
Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza
Collin, N., & de Radiguès, X. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.034 · Cited by 131
Ng, S., Cowling, B. J., Fang, V. J., Chan, K. H., Ip, D., Cheng, C. K. Y., Uyeki, T. M., Houck, P. M., Peiris, M. J. S., & Leung, G. M. (2010) · Clinical Infectious Diseases · doi:10.1086/650458 · Cited by 121
Clinical features of influenza A and B in children and association with myositis.
Hu, J., Kao, C., Lee, P., Chen, C., Lee, C., Lu, C., & Huang, L. (2004) · PubMed · Cited by 120
Irving, S. A., Patel, D., Kieke, B. A., Donahue, J. G., Vandermause, M., Shay, D. K., & Belongia, E. A. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00263.x · Cited by 103
Beran, J., Wertzova, V., Honegr, K., Kaliskova, E., Havlíčková, M., Havlík, J., Jiřincová, H., Belle, P. V., Jain, V., Innis, B. L., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-2 · Cited by 80
Hite, L. K., Glezen, W. P., Demmler, G. J., & Muñoz, F. M. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2005.10.008 · Cited by 76
Esposito, S., Cantarutti, L., Molteni, C. G., Daleno, C., Scala, A., Tagliabue, C., Pelucchi, C., Giaquinto, C., & Principi, N. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.02.015 · Cited by 71
Duration of Protection Provided by Live Attenuated Influenza Vaccine in Children
Ambrose, C. S., Yi, T., WALKER, R. E., & Connor, E. M. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318174e0f8 · Cited by 60
Self-citationLong time trends in influenza-like illness and associated determinants in The Netherlands
Dijkstra, F., Donker, G., Wilbrink, B., van Gageldonk‐Lafeber, A. B., & van der Sande, M. A. B. (2008) · Epidemiology and Infection · doi:10.1017/s095026880800126x · Cited by 58
Clinical Features of Children Infected With Different Strains of Influenza B in Southern Taiwan
Chi, C., Wang, S.-M., Lin, C.-C., Wang, H., Wang, J., Su, I., & Liu, C. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31816be008 · Cited by 55
Exploration of the emergence of the Victoria lineage of influenza B virus
Chen, J., Guo, Y.-J., Wu, K., Guo, J. F., Wang, M., Dong, J., Zhang, Y., Li, Z., & Shu, Y. (2006) · Archives of Virology · doi:10.1007/s00705-006-0852-6 · Cited by 50
Bettis, R. B., Iacuzio, D. A., Jung, T., Fuchs, R., Aultman, R., & Gyldmark, M. (2006) · Clinical Drug Investigation · doi:10.2165/00044011-200626060-00004 · Cited by 30
Shen, C., Huang, S.-C., Wang, S., Wang, J., & Liu, H. (2008) · PubMed · Cited by 25
Cited by
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,632
Highly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 866
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. S. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 593
After the pandemic: perspectives on the future trajectory of COVID-19
Telenti, A., Arvin, A., Corey, L., Corti, D., Diamond, M. S., García-Sastre, A., Garry, R. F., Holmes, E. C., Pang, P. S., & Virgin, H. W. (2021) · Nature · doi:10.1038/s41586-021-03792-w · Cited by 426
Current and next generation influenza vaccines: Formulation and production strategies
Soema, P. C., Kompier, R., Amorij, J.-P., & Kersten, G. F. A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.023 · Cited by 314
Metadata
- Authors
- Ambrose, C. S., & Levin, M. J.
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2012-01
- Volume
- 8
- Issue
- 1
- Pages
- 81-88
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- OpenAlex
- W2090460210
- Cited by
- 376
- References
- 26
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.